These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Kill kinetics and regrowth patterns of Pseudomonas aeruginosa exposed to concentration-time profiles of tobramycin simulating in vivo infusion and bolus dosing. Wood PJ; Ioannides-Demos LL; Bastone EB; Spicer WJ; McLean AJ Antimicrob Agents Chemother; 1996 May; 40(5):1321-4. PubMed ID: 8723496 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Mohamed AF; Nielsen EI; Cars O; Friberg LE Antimicrob Agents Chemother; 2012 Jan; 56(1):179-88. PubMed ID: 22037853 [TBL] [Abstract][Full Text] [Related]
7. Comparison of gentamicin dosing regimens using an in-vitro model. Begg EJ; Peddie BA; Chambers ST; Boswell DR J Antimicrob Chemother; 1992 Apr; 29(4):427-33. PubMed ID: 1607331 [TBL] [Abstract][Full Text] [Related]
8. Once-daily gentamicin therapy for experimental Escherichia coli meningitis. Ahmed A; París MM; Trujillo M; Hickey SM; Wubbel L; Shelton SL; McCracken GH Antimicrob Agents Chemother; 1997 Jan; 41(1):49-53. PubMed ID: 8980753 [TBL] [Abstract][Full Text] [Related]
10. [Dependence of the antimicrobial effect on the antibiotic concentration in modelling pharmacokinetic profiles in vitro: a comparison of 2 regimens for the single intravenous administration of sisomicin]. Firsov AA; Chernykh VM; Fomina IP Antibiot Med Biotekhnol; 1987 Sep; 32(9):685-93. PubMed ID: 3324953 [TBL] [Abstract][Full Text] [Related]
11. Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro. Gerber AU; Wiprächtiger P; Stettler-Spichiger U; Lebek G J Infect Dis; 1982 Apr; 145(4):554-60. PubMed ID: 6802906 [TBL] [Abstract][Full Text] [Related]
12. Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: meropenem bolus injections versus continuous infusions. Firsov AA; Mattie H Antimicrob Agents Chemother; 1997 Feb; 41(2):352-6. PubMed ID: 9021191 [TBL] [Abstract][Full Text] [Related]
13. Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve. Tisdale JE; Pasko MT; Mylotte JM Antimicrob Agents Chemother; 1989 Sep; 33(9):1500-5. PubMed ID: 2510592 [TBL] [Abstract][Full Text] [Related]
14. [In vitro study on the problem of optimal gentamicin therapy in leukopenic patients: short injections or parenteral infusions?]. Gerber A; Wiprächtiger P; Spichiger U; Lebek G Schweiz Med Wochenschr; 1979 Dec; 109(47):1902-3. PubMed ID: 119319 [TBL] [Abstract][Full Text] [Related]
15. Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example. Radivoyevitch T; Siranart N; Hlatky L; Sachs R AAPS J; 2015 Mar; 17(2):447-56. PubMed ID: 25663652 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Houlihan HH; Mercier RC; Rybak MJ Antimicrob Agents Chemother; 1997 Nov; 41(11):2497-501. PubMed ID: 9371356 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. Odenholt I; Cars O J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293 [TBL] [Abstract][Full Text] [Related]
18. [Bactericidal activity of antibiotics as a function of pharmacokinetic constants. II. Effect of pharmacokinetic parameters (C max and Ke) on the bactericidal activity of gentamicin]. Drugeon HB; Maurisset B; Chung SS; Courtieu AL Pathol Biol (Paris); 1982 Dec; 30(10):840-2. PubMed ID: 6760060 [TBL] [Abstract][Full Text] [Related]